Supplementary Figure 1 . Mass spectrometry profiles of methylation-modified FEN1. FEN1 was methylated in vitro by PRMT5 as described in Methods and subjected to Mass spectrometry analysis. (a a) Gluc digested peptide containing methylated R19. (b b) Gluc digested peptide containing methylated R100 and R104. Methylated arginine residues were shown in bold. 
Supplementary Results
Supplementary Figure 2 . Methylation of FEN1 has no effects on its activity, substrate or PCNA binding. (a a) Flap endonuclease activity assay. Top: Schematic of the DNA substrate used. Substrate was 32 P labeled at the 5' end of flap. Middle: FEN1 was subjected to in vitro methylation prior to activity assay. Products were analyzed on a 15% denatured PAGE, followed by autoradiography. Bottom: Quantification of the density of the cleavage products (P FEN ). (b b) Binding of methylated and non-methylated FEN1 to the flap DNA substrate. DNA binding was measured using the flap DNA substrate with a biotinylated 40 nt template strand immobilized onto streptavidin-magnetic beads. Binding assay was carried out on ice for 15 min. Bound FEN1 was determined by Western blotting assay using FEN1 specific antibody. Beads without the DNA construct were used as a negative control. (c c) Methylated and non-methylated FEN1 proteins were incubated with PCNA-coated Sepharose beads. Bead-bound FEN1 was detected by using FEN1 specific antibody. BSA-coated beads were used as a negative control. PRMT1  2009  26  119 PIWI  PRMT5  2009  27,28  120 TFR2  PRMT1  2009  29  121 TSP1  PRMT6  2009  30  122 S3  PRMT1  2009  31  123 PIAS1  PRMT1  2009  32  124 ICP27  PRMT1  2009  33,34  125 FGF-2  PRMT5  2009  35  126 SFRS9/SPR30  PRMT1  2009  36  127 C/EBP beta  PRMT1  2010  37  128 REF/ALY  PRMT1  2010  38  129 VASA  PRMT5  2010  39 
